Opendata, web and dolomites

ADMAIORA SIGNED

ADvanced nanocomposite MAterIals fOr in situ treatment and ultRAsound-mediated management of osteoarthritis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

ATTENTION there are some problems with word registering

 ADMAIORA project word cloud

Explore the words cloud of the ADMAIORA project. It provides you a very rough idea of what is the project "ADMAIORA" about.

osteoarthritis    joint    indirect    innovative    probes    trl    remote    lubrication    waves    ground    3d    lifespan    brace    disability    interventions    nanoparticles    paradigm    frame    arthroscopic    cells    conferring    models    respect    animal    handheld    demonstrated    delivered    admaiora    stimulating    degeneration    healthy    inflammatory    causes    regenerative    healthcare    60    90    billion    piezoelectric    technologies    middle    bioprinter    status    physician    preclinical    app    internet    stem    people    months    breaking    connection    aged    pain    treatment    surgical    weeks    citizens    time    showed    implanted    carbon    biosynthetic    mechanical    custom    equipped    untreated    avoiding    adipose    structures    materials    entrapped    elderly    stopping    things    patient    anti    experimental    direct    replacement    framework    nanomaterials    ultrasound    enormous    wireless    nanobiomaterial    total    considerably    quantified    tool    active    designed    burden    monitoring    disease    merge    responsivity    million    delaying    evolve    hydrogels    ones    oa    tissue    autologous    proof    slowing    revolutionize    cartilage    euros    situ   

Project "ADMAIORA" data sheet

The following table provides information about the project.

Coordinator
SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA 

Organization address
address: PIAZZA MARTIRI DELLA LIBERTA 33
city: PISA
postcode: 56127
website: www.sssup.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 5˙397˙480 €
 EC max contribution 5˙397˙480 € (100%)
 Programme 1. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-NMBP-TR-IND-2018
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SCUOLA SUPERIORE DI STUDI UNIVERSITARI E DI PERFEZIONAMENTO S ANNA IT (PISA) coordinator 1˙071˙500.00
2    ISTITUTO ORTOPEDICO RIZZOLI IT (BOLOGNA) participant 1˙112˙500.00
3    IMAGE GUIDED THERAPY SA FR (PESSAC) participant 670˙500.00
4    REGENTIS BIOMATERIALS LTD IL (OR AKIVA) participant 609˙250.00
5    HITECH DEVELOPMENT WIRELESS SWEDENAB SE (KISTA) participant 576˙930.00
6    BAR ILAN UNIVERSITY IL (RAMAT GAN) participant 524˙800.00
7    VIMEX SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (GLIWICE) participant 506˙375.00
8    PLASMACHEM PRODUKTIONS- UND HANDEL GMBH DE (BERLIN) participant 325˙625.00

Map

 Project objective

Osteoarthritis (OA) is a major burden that affects ~ 40 million of EU citizens, with enormous direct and indirect costs for the European healthcare systems, quantified in ~ 50.4 billion euros per year. This disease involves the degeneration of cartilage and other joint structures and is one of the most common causes of pain and disability in middle-aged and elderly people. ADMAIORA aims in the long-term at increasing the healthy and active lifespan of people affected by OA, by considerably slowing down or even stopping the degeneration process, thus delaying or avoiding surgical interventions for total joint replacement. Within the project time-frame the target is to achieve a 60% reduction of degeneration in OA animal models treated with the ADMAIORA technologies, with respect to control (untreated) ones, after 4 weeks, and a 90% reduction after 3 months. To achieve this ambitious objective the Consortium will evolve and merge technologies that already showed a high potential as experimental proof of concepts (TRL = 3) and will bring them at a preclinical level (TRL = 5). The ADMAIORA Consortium will develop biosynthetic hydrogels embedded with carbon-based nanomaterials, conferring higher mechanical and lubrication properties, and piezoelectric nanoparticles enabling responsivity to remote wireless ultrasound waves. Stem cells derived from autologous adipose tissue, which already demonstrated anti-inflammatory and regenerative properties, will be entrapped in the hydrogels. Materials and cells will be delivered in situ through an innovative handheld 3D bioprinter, embedded in an arthroscopic tool. A custom brace will be designed and equipped with ultrasound probes for both monitoring the joint status and stimulating the implanted piezoelectric nanobiomaterial. A dedicated App will allow a direct connection between patient and physician in an Internet of Things framework. Overall, ADMAIORA will target a ground-breaking paradigm that may revolutionize OA treatment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ADMAIORA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ADMAIORA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.3.;H2020-EU.2.1.2.)

MEFISTO (2019)

MEFISTO - Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy

Read More  

Repair3D (2019)

Recycling and Repurposing of Plastic Waste for Advanced 3D Printing Applications

Read More  

TBMED (2019)

A testing bed for the development of high-risk medical devices

Read More